# FDA Inspection 991523 - TMC/Higgins General Hospital - October 26, 2016

Source: https://www.globalkeysolutions.net/records/fda_inspections/tmchiggins-general-hospital/c2e51a9d-0ce2-442f-9850-f682c5379f12
Source feed: FDA_Inspections

> FDA Inspection 991523 for TMC/Higgins General Hospital on October 26, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 991523
- Company Name: TMC/Higgins General Hospital
- Inspection Date: 2016-10-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1072635 - 2018-10-31](https://www.globalkeysolutions.net/records/fda_inspections/tmchiggins-general-hospital/cb7ecbad-3f05-4e4f-a9ec-6a90c9dafe1d)
- [FDA Inspection 991523 - 2016-10-26](https://www.globalkeysolutions.net/records/fda_inspections/tmchiggins-general-hospital/0e6480b5-6d50-433c-8c9c-365ae8f45a1f)
- [FDA Inspection 768494 - 2012-02-22](https://www.globalkeysolutions.net/records/fda_inspections/tmchiggins-general-hospital/7a7f3fa4-0f4b-4bbd-a514-6e64b4fbb461)

Company: https://www.globalkeysolutions.net/companies/tmchiggins-general-hospital/80ce3b97-ca41-44e1-be4a-5dc5a97414ee

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d